Masaya Hata, CMP General Manager (Sales), commented:
“The extensive test applications we have made including
Selektope have led us to plan for this coating to perform as a
five-year period antifouling coating. We are convinced that
our customers will save fuel using this coating; our plan is to
evaluate performance on a working ship and position the
new antifouling coating in the market over the coming three
Selektope is patent-protected in antifouling applications in
all key shipbuilding and repair countries until 2026. Chaabane
points out that a second safeguard against imitation is
provided by the protection of original data by EU law, as well
as the extensive documentation required to support
acceptance of active substances under the EU Biocidal
SELEKTOPE® — FURTHER IMPROVING ANTIFOULING PAINTS
Selektope introduces for the first time ever a
pharmacological mode of action to combat barnacle
settlement. By temporarily stimulating the octopamine
receptor, the barnacle larvae’s swimming behaviour is
activated and the organisms are deterred from the hull.
These ground-breaking discoveries enable unrivalled power at
very low concentrations, yet within the limits of rigorous risk
assessments. Selektope is an organic, non-metal compound
with efficacy proven at 0.1% w/w.
I-Tech is a Gothenburg based bio-tech company with global
reach, holding all IP and regulatory rights to its all new
antifouling agent Selektope (generic name, medetomidine).
The company is privately held and is supported by
Swedish Energy Association, the European Innovation
Initiative Eco-Innovation and FP7 SeaFront. The company is a
member of the Astra Zeneca BioVentureHub.